The Ohio State University · 11 hours ago
Researcher 3 - Comprehensive Cancer Center
The Ohio State University is seeking a Researcher 3 for their Comprehensive Cancer Center. The role involves conducting experiments in cytogenetics and molecular genetics, coordinating research data analysis, and preparing research papers while ensuring regulatory compliance.
EducationHigher EducationUniversities
Responsibilities
Participates in the research of the Cytogenetics Lab in collaboration with the Department of Pathology
Conducts experiments and procedures in cytogenetics, molecular genetics, PCR applications, nick translation, tissue culture and growth of YACs and BACs
Establishes new research methods
Coordinates processing and analysis of research data
Prepares research papers
Maintains CLIA certification ensuring regulatory compliance
Serves as consultant to the principal investigator
Qualification
Required
Master's Degree required; Doctorate (desired)
Completed additional graduate course work in genetics required
Considerable research experience, preferably in cytogenetics, required
Knowledge of molecular genetics and classical cytogenetics required including karyotyping
Proficiency in FISH techniques required
Proficiency using web-based databases required
Ability to work independently required
Preferred
Experience in a progressively responsible administrative capacity desired
Computer proficiency desired with knowledge of spreadsheet and presentation software applications
Company
The Ohio State University
The Ohio State University is a public research university based in Columbus, Ohio.
H1B Sponsorship
The Ohio State University has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (311)
2024 (295)
2023 (236)
2022 (149)
2021 (111)
2020 (125)
Funding
Current Stage
Late StageTotal Funding
$52.28MKey Investors
AmeriCorps Public AlliesNational Safety CouncilFederal Aviation Administration
2024-07-09Grant· $0.81M
2024-04-29Grant
2024-03-05Grant· $0.35M
Recent News
Sports Business Journal
2025-10-24
Company data provided by crunchbase